Annals of Oncology

in this issue

in this issue
Ann Oncol 2009 20: 397; doi:10.1093/annonc/mdp042 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials

A. Gupta, D. Church, D. Barnes, and A. B. Hassan

Cut to the chase: on the need for genotype-specific soft tissue sarcoma trials
Ann Oncol 2009 20: 399-400; doi:10.1093/annonc/mdp021 [Extract] [Full Text] [PDF] [Request Permissions]  

K. J. Ruddy and A. H. Partridge

Adherence with adjuvant hormonal therapy for breast cancer
Ann Oncol 2009 20: 401-402; doi:10.1093/annonc/mdp039 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews

Get checked abstract C. McCabe, L. Bergmann, N. Bosanquet, M. Ellis, H. Enzmann, M. von Euler, B. Jönsson, K.-J. Kallen, D. Newling, V. Nüssler, B. Paschen, R. de Wilde, N. Wilking, C. Teale, H. Zwierzina, and Biotherapy Development Association

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective
Annals of Oncology Advance Access published on October 14, 2008
Ann Oncol 2009 20: 403-412; doi:10.1093/annonc/mdn603 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract J. Ruan, K. Hajjar, S. Rafii, and J. P. Leonard

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
Annals of Oncology Advance Access published on December 16, 2008
Ann Oncol 2009 20: 413-424; doi:10.1093/annonc/mdn666 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles

sarcomas

Get checked abstract A. Italiano, N. Penel, Y.-M. Robin, B. Bui, A. Le Cesne, S. Piperno-Neumann, M. Tubiana-Hulin, E. Bompas, C. Chevreau, N. Isambert, S. Leyvraz, P. P. du Chatelard, A. Thyss, J.-M. Coindre, and J.-Y. Blay

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group
Annals of Oncology Advance Access published on December 16, 2008
Ann Oncol 2009 20: 425-430; doi:10.1093/annonc/mdn678 [Abstract] [Full Text] [PDF] [Request Permissions]  

breast cancer

Get checked abstract V. Ziller, M. Kalder, U.-S. Albert, W. Holzhauer, M. Ziller, U. Wagner, and P. Hadji

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 431-436; doi:10.1093/annonc/mdn646 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract R. Yerushalmi, M. R. Kramer, S. Rizel, A. Sulkes, K. Gelmon, T. Granot, V. Neiman, and S. M. Stemmer

Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study
Annals of Oncology Advance Access published on January 12, 2009
Ann Oncol 2009 20: 437-440; doi:10.1093/annonc/mdn652 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract T. Liu, Y. Niu, Y. Yu, Y. Liu, and F. Zhang

Increased -tubulin expression and P16^INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast
Annals of Oncology Advance Access published on January 8, 2009
Ann Oncol 2009 20: 441-448; doi:10.1093/annonc/mdn651 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Roy, B. R. LaPlant, G. G. Gross, C. L. Bane, F. M. Palmieri, and for the North Central Cancer Treatment Group

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
Annals of Oncology Advance Access published on December 15, 2008
Ann Oncol 2009 20: 449-453; doi:10.1093/annonc/mdn661 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Antón, A. Ruiz, M. A. Seguí, L. Calvo, M. Muñoz, J. Lao, F. Sancho, and L. Fernández

Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
Annals of Oncology Advance Access published on December 11, 2008
Ann Oncol 2009 20: 454-459; doi:10.1093/annonc/mdn663 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract E. D. Saad and A. Katz

Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined
Annals of Oncology Advance Access published on December 18, 2008
Ann Oncol 2009 20: 460-464; doi:10.1093/annonc/mdn670 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract P. G. Gobbi, F. Corbella, F. Valentino, M. Bergonzi, C. Sangalli, V. Perfetti, and G. R. Corazza

Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy
Annals of Oncology Advance Access published on December 11, 2008
Ann Oncol 2009 20: 465-468; doi:10.1093/annonc/mdn668 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Bengala, S. Bettelli, F. Bertolini, S. Salvi, S. Chiara, C. Sonaglio, L. Losi, N. Bigiani, G. Sartori, C. Dealis, N. Malavasi, R. D'Amico, G. Luppi, B. Gatteschi, A. Maiorana, and P. F. Conte

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer
Annals of Oncology Advance Access published on December 18, 2008
Ann Oncol 2009 20: 469-474; doi:10.1093/annonc/mdn647 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract P. C. Enzinger, D. P. Ryan, J. W. Clark, A. Muzikansky, C. C. Earle, M. H. Kulke, J. A. Meyerhardt, L. S. Blaszkowsky, A. X. Zhu, P. Fidias, M. M. Vincitore, R. J. Mayer, and C. S. Fuchs

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
Annals of Oncology Advance Access published on January 12, 2009
Ann Oncol 2009 20: 475-480; doi:10.1093/annonc/mdn658 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract E. Goekkurt, S.-E. Al-Batran, U. Mogck, C. Pauligk, J. T. Hartmann, M. Kramer, E. Jaeger, G. Ehninger, and J. Stoehlmacher

Pharmacogenetic analyses of hematotoxicity in advanced gastric cancer patients receiving biweekly fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Annals of Oncology Advance Access published on December 12, 2008
Ann Oncol 2009 20: 481-485; doi:10.1093/annonc/mdn667 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung Cancer

Get checked abstract R. de Boer, Y. Humblet, J. Wolf, L. Nogová, K. Ruffert, T. Milenkova, R. Smith, A. Godwood, and J. Vansteenkiste

An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancer
Annals of Oncology Advance Access published on December 16, 2008
Ann Oncol 2009 20: 486-491; doi:10.1093/annonc/mdn674 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract A. Hussain, R. S. DiPaola, A. D. Baron, C. S. Higano, N. S. Tchekmedyian, and A. R. Johri

Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer
Annals of Oncology Advance Access published on December 15, 2008
Ann Oncol 2009 20: 492-497; doi:10.1093/annonc/mdn665 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract G. Spitaleri, D. V. Matei, G. Curigliano, S. Detti, F. Verweij, S. Zambito, E. Scardino, B. Rocco, F. Nolè, L. Ariu, T. De Pas, F. de Braud, and O. De Cobelli

Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer
Annals of Oncology Advance Access published on January 12, 2009
Ann Oncol 2009 20: 498-502; doi:10.1093/annonc/mdn650 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract J. Dupuis, E. Itti, A. Rahmouni, F. Hemery, C. Gisselbrecht, C. Lin, C. Copie-Bergman, K. Belhadj, T. El Gnaoui, I. Gaillard, F. Kuhnowski, M. Meignan, and C. Haioun

Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating ¹⁸fluorodeoxyglucose positron emission tomography to the International Workshop Criteria
Annals of Oncology Advance Access published on December 11, 2008
Ann Oncol 2009 20: 503-507; doi:10.1093/annonc/mdn671 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Noy, H. Schöder, M. Gönen, M. Weissler, K. Ertelt, C. Cohler, C. Portlock, P. Hamlin, and H. W. D. Yeung

The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
Annals of Oncology Advance Access published on January 12, 2009
Ann Oncol 2009 20: 508-512; doi:10.1093/annonc/mdn657 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract M. Moreau, J. Klastersky, A. Schwarzbold, F. Muanza, A. Georgala, M. Aoun, A. Loizidou, M. Barette, S. Costantini, M. Delmelle, L. Dubreucq, M. Vekemans, A. Ferrant, D. Bron, and M. Paesmans

A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies
Annals of Oncology Advance Access published on January 12, 2009
Ann Oncol 2009 20: 513-519; doi:10.1093/annonc/mdn655 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Goy, S. H. Bernstein, B. S. Kahl, B. Djulbegovic, M. J. Robertson, S. de Vos, E. Epner, A. Krishnan, J. P. Leonard, S. Lonial, S. Nasta, O. A. O'Connor, H. Shi, A. L. Boral, and R. I. Fisher

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
Annals of Oncology Advance Access published on December 12, 2008
Ann Oncol 2009 20: 520-525; doi:10.1093/annonc/mdn656 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract D. Ennishi, M. Yokoyama, Y. Terui, H. Asai, S. Sakajiri, Y. Mishima, S. Takahashi, H. Komatsu, K. Ikeda, K. Takeuchi, M. Tanimoto, and K. Hatake

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy
Annals of Oncology Advance Access published on December 12, 2008
Ann Oncol 2009 20: 526-533; doi:10.1093/annonc/mdn677 [Abstract] [Full Text] [PDF] [Request Permissions]  

head and neck cancer

Get checked abstract C. S. Furniss, M. D. McClean, J. F. Smith, J. Bryan, K. M. Applebaum, H. H. Nelson, M. R. Posner, and K. T. Kelsey

Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use
Annals of Oncology Advance Access published on December 15, 2008
Ann Oncol 2009 20: 534-541; doi:10.1093/annonc/mdn643 [Abstract] [Full Text] [PDF] [Request Permissions]  

supportive care

Get checked abstract C. L. Loprinzi, A. C. Dueck, B. S. Khoyratty, D. L. Barton, S. Jafar, K. M. Rowland, Jr, P. J. Atherton, G. W. Marsa, W. H. Knutson, J. D. Bearden, III, L. Kottschade, and T. R. Fitch

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)
Annals of Oncology Advance Access published on January 6, 2009
Ann Oncol 2009 20: 542-549; doi:10.1093/annonc/mdn644 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology

Get checked abstract P. Boffetta, M. Tubiana, C. Hill, M. Boniol, A. Aurengo, R. Masse, A.-J. Valleron, R. Monier, G. de Thé, P. Boyle, and P. Autier

The causes of cancer in France
Annals of Oncology Advance Access published on September 2, 2008
Ann Oncol 2009 20: 550-555; doi:10.1093/annonc/mdn597 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. M. Mousavi, M. M. Gouya, R. Ramazani, M. Davanlou, N. Hajsadeghi, and Z. Seddighi

Cancer incidence and mortality in Iran
Annals of Oncology Advance Access published on December 10, 2008
Ann Oncol 2009 20: 556-563; doi:10.1093/annonc/mdn642 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Gondos, F. Bray, T. Hakulinen, H. Brenner, and the EUNICE Survival Working Group

Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis
Annals of Oncology Advance Access published on December 9, 2008
Ann Oncol 2009 20: 564-573; doi:10.1093/annonc/mdn639 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract K. Hemminki, X. Li, J. Sundquist, and K. Sundquist

Cancer risks in Crohn disease patients
Annals of Oncology Advance Access published on September 2, 2008
Ann Oncol 2009 20: 574-580; doi:10.1093/annonc/mdn595 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Edefonti, G. Randi, A. Decarli, C. La Vecchia, C. Bosetti, S. Franceschi, L. Dal Maso, and M. Ferraroni

Clustering dietary habits and the risk of breast and ovarian cancers
Annals of Oncology Advance Access published on October 7, 2008
Ann Oncol 2009 20: 581-590; doi:10.1093/annonc/mdn594 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

A. P. Polednak

Recognition of comorbid diabetes and obesity in hospital records of newly diagnosed cancer patients
Annals of Oncology Advance Access published on January 23, 2009
Ann Oncol 2009 20: 591-592; doi:10.1093/annonc/mdn754 [Extract] [Full Text] [PDF] [Request Permissions]  

A. Vazquez-Martin, C. Oliveras-Ferraros, S. del Barco, B. Martin-Castillo, and J. A. Menendez

The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 592-595; doi:10.1093/annonc/mdn758 [Extract] [Full Text] [PDF] [Request Permissions]  

P. Bono, P.-L. Kellokumpu-Lehtinen, T. Alanko, R. Kokko, R. Asola, T. Turpeenniemi-Hujanen, S. Jyrkkiö, V. Kataja, M. Leinonen, and H. Joensuu

Docetaxel 100 versus 80 mg/m² as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 595-596; doi:10.1093/annonc/mdn771 [Extract] [Full Text] [PDF] [Request Permissions]  

Y. Loriot, P. Mordant, and E. Deutsch

Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?
Annals of Oncology Advance Access published on January 22, 2009
Ann Oncol 2009 20: 596-597; doi:10.1093/annonc/mdn772 [Extract] [Full Text] [PDF] [Request Permissions]  

G. Palmieri

Reply to Antisense oligonucleotide targeting Bcl-2 mRNA in cancer; bad drug, bad target, neither or both?
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 597; doi:10.1093/annonc/mdn773 [Extract] [Full Text] [PDF] [Request Permissions]  

L. Willems, F. Suarez, N. Baubion, D. Decaudin, D. Ghez, O. Hermine, B. Varet, and M.-T. Rubio

High risk of cardiac dysfunction after treatment of secondary acute myeloid leukaemia to breast cancer
Annals of Oncology Advance Access published on January 27, 2009
Ann Oncol 2009 20: 597-599; doi:10.1093/annonc/mdn776 [Extract] [Full Text] [PDF] [Request Permissions]  

I. M. E. Desar, D. M. Burger, Q. G. C. M. Van Hoesel, J. H. Beijnen, C. M. L. Van Herpen, and W. T. A. Van der Graaf

Pharmacokinetics of sunitinib in an obese patient with a GIST
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 599-600; doi:10.1093/annonc/mdn779 [Extract] [Full Text] [PDF] [Request Permissions]  

J. Ayllon, V. Launay-Vacher, J. Medioni, C. Cros, J. P. Spano, and S. Oudard

Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
Annals of Oncology Advance Access published on February 2, 2009
Ann Oncol 2009 20: 600-601; doi:10.1093/annonc/mdn788 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.